Dai Sato

Siglec-15-targeting therapy increases bone mass in rats without impairing skeletal growth

Dai Sato, Masahiko Takahata, Masahiro Ota et al. · Bone · 2018 · 32 citations

Mechanobiology, Sclerostin, Bone Morphogenic Protein +11

Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemia

Masahiro Ota, Masahiko Takahata, Tomohiro Shimizu et al. · Osteoporosis International · 2016 · 28 citations

Secondary Hyperparathyroidism, Renal Disease, Osteoporosis Medications +13

Assessment of valgus laxity after release of the medial structure in medial open-wedge high tibial osteotomy: an in vivo biomechanical study using quantitative valgus stress radiography

Dai Sato, Eiji Kondo, Koji Yabuuchi et al. · BMC Musculoskeletal Disorders · 2019 · 24 citations · Full text

Siglec-15-targeting therapy protects against glucocorticoid-induced osteoporosis of growing skeleton in juvenile rats

Dai Sato, Masahiko Takahata, Masahiro Ota et al. · Bone · 2020 · 24 citations

Bone Disease, Juvenile Rats, Orthopaedic Surgery +8

Identification of Galectin-2–Mucin Interaction and Possible Formation of a High Molecular Weight Lattice

Mayumi Tamura, Dai Sato, Moeko Nakajima et al. · Biological and Pharmaceutical Bulletin · 2017 · 20 citations · Full text

Glycobiology, Molecular Biology, Polysaccharide +16